Structural, Biochemical, and Computational Studies Reveal the Mechanism of Selective Aldehyde Dehydrogenase 1A1 Inhibition by Cytotoxic Duocarmycin Analogues
- 16 September 2015
- journal article
- zuschrift
- Published by Wiley in Angewandte Chemie
- Vol. 127 (46) , 13754-13758
Abstract
Analogues of the natural product duocarmycin bearing an indole moiety were shown to bind aldehyde dehydrogenase 1A1 (ALDH1A1) in addition to DNA, while derivatives without the indole solely addressed the ALDH1A1 protein. The molecular mechanism of selective ALDH1A1 inhibition by duocarmycin analogues was unraveled through cocrystallization, mutational studies, and molecular dynamics simulations. The structure of the complex shows the compound embedded in a hydrophobic pocket, where it is stabilized by several crucial π‐stacking and van der Waals interactions. This binding mode positions the cyclopropyl electrophile for nucleophilic attack by the noncatalytic residue Cys302, thereby resulting in covalent attachment, steric occlusion of the active site, and inhibition of catalysis. The selectivity of duocarmycin analogues for ALDH1A1 is unique, since only minor alterations in the sequence of closely related protein isoforms restrict compound accessibility.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft
- VW-Stiftung and State of Lower Saxony
- SFB749
- CIPSM
- Fonds der Chemischen Industrie
This publication has 31 references indexed in Scilit:
- Duocarmycin Analogues Target Aldehyde Dehydrogenase 1 in Lung Cancer CellsAngewandte Chemie International Edition, 2012
- Duocarmycin Analogues Target Aldehyde Dehydrogenase 1 in Lung Cancer CellsAngewandte Chemie, 2012
- The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistanceChemico-Biological Interactions, 2012
- Discovery of a Novel Class of Covalent Inhibitor for Aldehyde DehydrogenasesJournal of Biological Chemistry, 2011
- Glycosidic Prodrugs of Highly Potent Bifunctional Duocarmycin Derivatives for Selective Treatment of CancerAngewandte Chemie International Edition, 2010
- Glycosidische Prodrugs hochpotenter difunktioneller Duocarmycin‐Derivate für eine selektive TumortherapieAngewandte Chemie, 2010
- Determination of the Biological Activity and Structure Activity Relationships of Drugs Based on the Highly Cytotoxic Duocarmycins and CC-1065Toxins, 2009
- Probing the Mechanism of Action of Potential Anticancer Agents at a Molecular Level Using Electrospray Ionisation Fourier Transform Ion Cyclotron Resonance Mass SpectrometryEuropean Journal of Mass Spectrometry, 2009
- Fundamental Relationships between Structure, Reactivity, and Biological Activity for the Duocarmycins and CC-1065Journal of Medicinal Chemistry, 2009
- Hydrogen Bonding and π-Stacking: How Reliable are Force Fields? A Critical Evaluation of Force Field Descriptions of Nonbonded InteractionsJournal of Chemical Information and Modeling, 2009